|By PR Newswire||
|September 4, 2014 06:15 PM EDT||
WAYNE, Pa., Sept. 4, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of Marrone Bio Innovations, Inc. ("Marrone Bio" or the "Company") (NASDAQ: MBII).
Marrone Bio shareholders who purchased Marrone Bio shares should contact Richard A. Maniskas, Esquire at 877-316-3218 or at [email protected] to learn more about this investigation or visit: www.rmclasslaw.com/cases/mbii.
On September 3, 2014 Marrone Bio shocked the market when it announced that its Audit Committee has commenced an internal investigation concerning revenue recognition in the fourth quarter of 2013. The Company also stated that its financial statements for fiscal year 2013, and the first two quarters of 2014, should no longer be relied upon by investors. In intraday trading on September 3, 2014, this adverse news caused Marrone Bio's stock to fall more than 40%.
If you own Marrone Bio shares and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit: www.rmclasslaw.com/cases/mbii. You may also email Mr. Maniskas at [email protected]. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
SOURCE Ryan & Maniskas, LLP